Orchid Chemicals | Nseguide.com

Quotes with Resistance & Support

Market Information

Intraday calls for 24-09-10

Posted on: September 24th 2010 in Intraday Tips, Daytrading, Intraday tips for free NSE BSE Breakouts Daily intraday tips calls.

Markets likely to open flat. Nifty has support at 5930 and resistance at 6050 Buy Orchid Chemicals & Pharmaceuticals Ltd at 205-208, target: 214. Stoploss:199 Trade in small quantities 9.23am – Book profit in Tube investments at 148 …

Read More..

Intraday calls for 07-08-09

Posted on: August 7th 2009 in Intraday Tips, Daytrading, Intraday tips for free NSE BSE Breakouts Daily intraday tips calls.

Markets likely to see gap down opening. No sell calls considering we will see a gap down. Shall update sell calls during market hours. If markets show recovery later during the day, buy Orchid Chemicals. …

Read More..

Intraday calls for 07-06-09

Posted on: July 7th 2009 in Intraday Tips, Daytrading, Intraday tips for free NSE BSE Breakouts Daily intraday tips calls.

Nifty has strong support at 4080-4150 level and is likely to see some bounce from current levels. Buy Punj Lloyd at 199, target: 206. Stoploss: 196 Buy Reliance Industries at 1894, target: 1920. Stoploss: 1886. If markets show weakness later during the day, short: Orchid Chemicals. …

Read More..

Buy Orchid Chemicals, target of Rs 176: Reliance Money

Posted on: June 13th 2009 in Brokerage Recommendations.

Reliance Money has recommended a buy rating on Orchid Chemicals and Pharmaceuticals with a target price of Rs 176 in its June 12, 2009 research report. “Orchid Chemicals & Pharmaceuticals (Orchid) is an integrated pharmaceutical company with core competencies in the cephalospo…

Read More..

Buy Orchid Chemicals, target of Rs 163: Sharekhan

Posted on: June 8th 2009 in Brokerage Recommendations.

Sharekhan has maintained its buy rating on Orchid Chemicals & Pharmaceuticals, with price target of Rs 163, in its report dated June 5, 2009. “At the current market price of Rs 136, Orchid is discounting its FY2009E earnings by 10.7x and its FY2010E earnings by 8.3x. Though th…

Read More..